• 1
    Beier R., Gebert A. (1998) Kinetics of particle uptake in the domes of Peyer's patches. Am J Physiol-Gastr L 275: G1307.
  • 2
    Schreuder M.P., Deen C., Boersma W.J.A., Pouwels P.H., Klis F.M. (1996) Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine 14: 3838.
  • 3
    Shin S.J., Bae J.L., Cho Y.W., Lee D.Y., Kim D.H., Yang M.S., Jang Y.S., Yoo H.S. (2005) Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. Fems Immunol Med Mic 43: 15564.
  • 4
    Kulkarni R.R., Parreira V.R., Jiang Y.F., Prescott J.F. (2010) A live oral recombinant Salmonella enterica Serovar Typhimurium vaccine expressing Clostridium perfringens antigens confers protection against necrotic enteritis in broiler chickens. Clin Vaccine Immunol 17: 20514.
  • 5
    Scheppler L., Vogel M., Zuercher A.W., Zuercher M., Germond J.E., Miescher S.M., Stadler B.M. (2002) Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 20: 291320.
  • 6
    Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., Franzusoff A., Duke R.C., Wilson C.C. (2001) Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 7: 6259.
  • 7
    Park S.M., Mo A.Y., Lim J.G., Chung H.J., Kim T.G., Kim K.J., Cho D.H., Yang M.S., Kim D.H. (2007) Surface displayed expression of a neutralizing epitope of spike protein from a Korean strain of porcine epidemic diarrhea virus. Biotechnol Bioproc E 12: 6905.
  • 8
    Ueda M., Tanaka A. (2000) Cell surface engineering of yeast: construction of arming yeast with biocatalyst. J Biosci Bioeng 90: 12536.
  • 9
    Kim J.M., Jung D.I., Eom Y.J., Park S.M., Yoo H.S., Jang Y.S., Yang M.S., Kim D.H. (2010) Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae. Biosci Biotech Bioch 74: 13627.
  • 10
    Haesebrouck F., Chiers K., Van Overbeke I., Ducatelle R. (1997) Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 58: 23949.
  • 11
    Bosse J.T., Janson H., Sheehan B.J., Beddek A.J., Rycroft A.N., Kroll J.S., Langford P.R. (2002) Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect 4: 22535.
  • 12
    Lee K.Y., Kim D.H., Kang T.J., Kim J., Chung G.H., Yoo H.S., Arntzen C.J., Yang M.S., Jang Y.S. (2006) Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol Med Microbiol 48: 3819.
  • 13
    Seo K.W., Kim D.H., Kim A.H., Yoo H.S., Lee K.Y., Jang Y.S. (2011) Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge. Immunol Invest 40: 46580.
  • 14
    Shin S.J., Shin S.W., Kang M.L., Lee D.Y., Yang M.S., Jang Y.S., Yoo H.S. (2007) Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice. J Vet Sci 8: 38392.
  • 15
    Lutz M.B., Kukutsch N., Ogilvie A.L.J., Rossner S., Koch F., Romani N., Schuler G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 7792.
  • 16
    Shin M.K., Jung M.H., Lee W.J., Choi P.S., Jang Y.S., Yoo H.S. (2011) Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate. J Vet Sci 12: 4013.
  • 17
    Jackson R.J., Fujihashi K., Xuamano J.C., Kiyono H., Elson C.O., Mcghee J.R. (1993) Optimizing oral vaccines—induction of systemic and mucosal B-cell and antibody-responses to tetanus toxoid by use of cholera-toxin as an adjuvant. Infect Immun 61: 42729.
  • 18
    Rosa D.S., Ribeiro S.P., Almeida R.R., Mairena E.C., Postol E., Kalil J., Cunha-Neto E. (2011) A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4(+) and CD8(+) T cell responses. PLoS One 6: e16921. doi: 10.1371/journal.pone.0016921
  • 19
    Shin M.K., Kang M.L., Bin Cha S., Lee W.J., Sung J.H., Yoo H.S. (2011) An immunosorbent assay based on the recombinant ApxIA, ApxIIA, and ApxIIIA toxins of Actinobacillus pleuropneumoniae and its application to field sera. J Vet Diagn Invest 23: 73642.
  • 20
    Shin M.K., Kang M.L., Jung M.H., Cha S.B., Lee W.J., Kim J.M., Kim D.H., Yoo H.S. (2013) Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs. Vet Immunol Immunopathol 151: 1329.
  • 21
    Lipscomb M.F., Masten B.J. (2002) Dendritic cells: immune regulators in health and disease. Physiol Rev 82: 97130.
  • 22
    Remer K.A., Bartrow M., Roeger B., Moll H., Sonnenborn U., Oelschlaeger T.A. (2009) Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. Int J Med Microbiol 299: 46778.
  • 23
    Fahlen-Yrlid L., Gustafsson T., Westlund J., Holmberg A., Strombeck A., Blomquist M., Macpherson G.G., Holmgren J., Yrlid U. (2009) CD11c(high) dendritic cells are essential for activation of CD4(+) T cells and generation of specific antibodies following mucosal immunization. J Immunol 183: 503241.
  • 24
    Jang M.H., Kweon M.N., Iwatani K., Yamamoto M., Terahara K., Sasakawa C., Suzuki T., Nochi T., Yokota Y., Rennert P.D., Hiroi T., Tamagawa H., Iijima H., Kunisawa J., Yuki Y., Kiyono H. (2004) Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 101: 61105.
  • 25
    Lefrancois L., Lycke N. (2001) Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. Curr Protoc Immunol Chapter 3: Unit 3, 19. doi: 10.1002/0471142735.im0319s17